Table 1.
Input | Value | Sources |
---|---|---|
Target population by country | Approximately 90 million pregnant women globally, per year | United Nations Population Database, 2017 and Lawn et al., 2016 [11], [12] |
Vaccine schedule | Single dose provided year-round as part of ANC services | Preferred Product Characteristics [13]; expert opinion |
Vaccination window | 24–36 weeks of gestation | Preferred Product Characteristics [13]; expert opinion |
Vaccine coverage by country | Average in year 2023, 69% (21%–96%) | DHS and WHO [14], [15] |
Vaccine introduction dates by country | Phased, 2023 to 2035 | Product development timeline [8]; prior vaccine introduction |
Vaccine efficacy for infant protection | Midpoint 60% | Preferred Product Characteristics [13]; expert opinion |
Duration of protection | Midpoint 5 months, no waning before 5 months | Preferred Product Characteristics [13]; expert opinion |
Abbreviations: ANC, antenatal care; DHS, Demographic and Health Surveys; WHO, World Health Organization.